Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik B Rasmussen

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmacogenetics and Genomics|January 14, 2016
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitorsKarl E Nelveg-Kristensen, Majbritt B Madsen, Christian Torp-Pedersen, et al.
BMC Cancer|August 6, 2010
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple MyelomaAnnette J Vangsted, Karen Søeby, Tobias W Klausen, et al.
The Journal of Heredity|May 15, 2008
Population genetic structure of savannah elephants in Kenya: conservation and management implicationsJohn B A Okello, Charles Masembe, Henrik B Rasmussen, et al.
Nordic Journal of Psychiatry|November 13, 2015
Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disordersLouise K Hoeffding, Linh T T Duong, Andrés Ingason, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 16, 2009
The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysisPeter Saetre, Per Lundmark, August Wang, et al.
Neuropsychobiology|May 15, 2009
DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association studyErik G Jönsson, Peter Saetre, Maria Vares, et al.
Psychiatry Research|February 19, 2009
Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE)Srdjan Djurovic, Stephanie Le Hellard, Anna K Kähler, et al.
Schizophrenia Research|September 27, 2008
Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control samplePeter Saetre, Ingrid Agartz, Alessandra De Franciscis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 12, 2009
Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophreniaMaria Vares, Peter Saetre, Hong Deng, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 1, 2018
Pharmacometabolomics Informs About Pharmacokinetic Profile of MethylphenidateRima Kaddurah-Daouk, Thomas Hankemeier, Elizabeth H Scholl, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmacogenetics and Genomics|January 14, 2016
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitorsKarl E Nelveg-Kristensen, Majbritt B Madsen, Christian Torp-Pedersen, et al.
BMC Cancer|August 6, 2010
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple MyelomaAnnette J Vangsted, Karen Søeby, Tobias W Klausen, et al.
The Journal of Heredity|May 15, 2008
Population genetic structure of savannah elephants in Kenya: conservation and management implicationsJohn B A Okello, Charles Masembe, Henrik B Rasmussen, et al.
Nordic Journal of Psychiatry|November 13, 2015
Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disordersLouise K Hoeffding, Linh T T Duong, Andrés Ingason, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 16, 2009
The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysisPeter Saetre, Per Lundmark, August Wang, et al.
Neuropsychobiology|May 15, 2009
DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association studyErik G Jönsson, Peter Saetre, Maria Vares, et al.
Psychiatry Research|February 19, 2009
Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE)Srdjan Djurovic, Stephanie Le Hellard, Anna K Kähler, et al.
Schizophrenia Research|September 27, 2008
Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control samplePeter Saetre, Ingrid Agartz, Alessandra De Franciscis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 12, 2009
Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophreniaMaria Vares, Peter Saetre, Hong Deng, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 1, 2018
Pharmacometabolomics Informs About Pharmacokinetic Profile of MethylphenidateRima Kaddurah-Daouk, Thomas Hankemeier, Elizabeth H Scholl, et al.
Pageof 4